4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-050173
Chief Business Officer sold 1,261 shares at $9.41 ($11,866)
From the SEC's structured data for this filing
Trades in this filing
McNeill Jonathan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-18 | Sale : show line 1 in the form | −1,261 | $9.41 | $11,866 | 60,605 | D |
| Open-market sales · 1,261 sh · avg $9.41 · $11,866 | ||||||
Loading xslF345X05/doc4.xml…